{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:25:00Z","timestamp":1784586300832,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T00:00:00Z","timestamp":1341964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11926-012-0268-0","type":"journal-article","created":{"date-parts":[[2012,7,10]],"date-time":"2012-07-10T13:31:26Z","timestamp":1341927086000},"page":"383-389","source":"Crossref","is-referenced-by-count":14,"title":["Endoplasmic Reticulum Aminopeptidase 1 and Interleukin-23 Receptor in Ankylosing Spondylitis"],"prefix":"10.1007","volume":"14","author":[{"given":"Nigil","family":"Haroon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,11]]},"reference":[{"key":"268_CR1","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.1780401015","volume":"40","author":"MA Brown","year":"1997","unstructured":"Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 1997;40:1823\u20138.","journal-title":"Arthritis Rheum"},{"key":"268_CR2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/art.1780380313","volume":"38","author":"P Jarvinen","year":"1995","unstructured":"Jarvinen P. Occurrence of ankylosing spondylitis in a nationwide series of twins. Arthritis Rheum. 1995;38:381\u20133.","journal-title":"Arthritis Rheum"},{"key":"268_CR3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(73)91360-3","volume":"1","author":"DA Brewerton","year":"1973","unstructured":"Brewerton DA, Hart FD, Nicholls A, et al. Ankylosing spondylitis and HL-A 27. Lancet. 1973;1:904\u20137.","journal-title":"Lancet"},{"key":"268_CR4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/ard.59.11.883","volume":"59","author":"MA Brown","year":"2000","unstructured":"Brown MA, Laval SH, Brophy S, et al. Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2000;59:883\u20136.","journal-title":"Ann Rheum Dis"},{"key":"268_CR5","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1086\/319509","volume":"68","author":"SH Laval","year":"2001","unstructured":"Laval SH, Timms A, Edwards S, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet. 2001;68:918\u201326.","journal-title":"Am J Hum Genet"},{"key":"268_CR6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ng.2007.17","volume":"39","author":"PR Burton","year":"2007","unstructured":"Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC), Burton PR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39:1329\u201337.","journal-title":"Nat Genet"},{"key":"268_CR7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature01074","volume":"419","author":"T Serwold","year":"2002","unstructured":"Serwold T, Gonzalez F, Kim J, et al. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature. 2002;419:480\u20133.","journal-title":"Nature"},{"key":"268_CR8","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ni859","volume":"3","author":"T Saric","year":"2002","unstructured":"Saric T, Chang SC, Hattori A, et al. An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol. 2002;3:1169\u201376.","journal-title":"Nat Immunol"},{"key":"268_CR9","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/art.24467","volume":"60","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych WP, Inman RD, Gladman DD, et al. Association of a specific ERAP1\/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum. 2009;60:1317\u201323.","journal-title":"Arthritis Rheum"},{"key":"268_CR10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/BOR.0b013e3283364483","volume":"22","author":"MA Brown","year":"2010","unstructured":"\u2022 Brown MA. Genetics of ankylosing spondylitis. Curr Opin Rheumatol. 2010;22:126\u201332. A good review of the genetics of ankylosing spondylitis.","journal-title":"Curr Opin Rheumatol"},{"key":"268_CR11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/ard.2008.103804","volume":"69","author":"FW Tsui","year":"2010","unstructured":"\u2022\u2022 Tsui FW, Haroon N, Reveille JD, et al. Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis. Ann Rheum Dis. 2010;69:733\u20136. This is the first publication to show a possible role of ERAP2 in ankylosing spondylitis.","journal-title":"Ann Rheum Dis"},{"key":"268_CR12","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00011-011-0374-x","volume":"60","author":"YH Lee","year":"2011","unstructured":"Lee YH, Choi SJ, Ji JD, et al. Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Inflamm Res. 2011;60:999\u20131003.","journal-title":"Inflamm Res"},{"key":"268_CR13","doi-asserted-by":"crossref","first-page":"e3658","DOI":"10.1371\/journal.pone.0003658","volume":"3","author":"I Evnouchidou","year":"2008","unstructured":"Evnouchidou I, Momburg F, Papakyriakou A, et al. The internal sequence of the peptide-substrate determines its N-terminus trimming by ERAP1. PLoS One. 2008;3:e3658.","journal-title":"PLoS One"},{"key":"268_CR14","doi-asserted-by":"crossref","first-page":"7745","DOI":"10.1073\/pnas.1101262108","volume":"108","author":"G Kochan","year":"2011","unstructured":"\u2022\u2022 Kochan G, Krojer T, Harvey D, et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci U S A. 2011;108:7745\u201350. One of the two initial papers describing the crystal structure of ERAP1.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"268_CR15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nsmb.2021","volume":"18","author":"TT Nguyen","year":"2011","unstructured":"Nguyen TT, Chang SC, Evnouchidou I, et al. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol. 2011;18:604\u201313. One of the two initial papers describing the crystal structure of ERAP1.","journal-title":"Nat Struct Mol Biol"},{"key":"268_CR16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI0213847","volume":"110","author":"X Cui","year":"2002","unstructured":"Cui X, Hawari F, Alsaaty S, et al. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest. 2002;110:515\u201326.","journal-title":"J Clin Invest"},{"key":"268_CR17","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.4049\/jimmunol.171.12.6814","volume":"171","author":"X Cui","year":"2003","unstructured":"Cui X, Rouhani FN, Hawari F, et al. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol. 2003;171:6814\u20139.","journal-title":"J Immunol"},{"key":"268_CR18","doi-asserted-by":"crossref","first-page":"28677","DOI":"10.1074\/jbc.M300456200","volume":"278","author":"X Cui","year":"2003","unstructured":"Cui X, Rouhani FN, Hawari F, et al. An aminopeptidase, ARTS-1, is required for interleukin-6 receptor shedding. J Biol Chem. 2003;278:28677\u201385.","journal-title":"J Biol Chem"},{"key":"268_CR19","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.3899\/jrheum.100019","volume":"37","author":"N Haroon","year":"2010","unstructured":"\u2022 Haroon N, Tsui FW, Chiu B, et al. Serum cytokine receptors in ankylosing spondylitis: relationship to inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms. J Rheumatol. 2010;37:1907\u201310. First functional study of ERAP1 in AS showing no role for receptor shedding function in ankylosing spondylitis.","journal-title":"J Rheumatol"},{"key":"268_CR20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coi.2007.12.004","volume":"20","author":"N Blanchard","year":"2008","unstructured":"Blanchard N, Shastri N. Coping with loss of perfection in the MHC class I peptide repertoire. Curr Opin Immunol. 2008;20:82\u20138.","journal-title":"Curr Opin Immunol"},{"key":"268_CR21","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.1073\/pnas.0500721102","volume":"102","author":"SC Chang","year":"2005","unstructured":"Chang SC, Momburg F, Bhutani N, et al. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a \"molecular ruler\" mechanism. Proc Natl Acad Sci U S A. 2005;102:17107\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"268_CR22","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ni860","volume":"3","author":"IA York","year":"2002","unstructured":"York IA, Chang SC, Saric T, et al. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat Immunol. 2002;3:1177\u201384.","journal-title":"Nat Immunol"},{"key":"268_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ni1409","volume":"8","author":"GE Hammer","year":"2007","unstructured":"Hammer GE, Gonzalez F, James E, et al. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol. 2007;8:101\u20138.","journal-title":"Nat Immunol"},{"key":"268_CR24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","volume":"43","author":"DM Evans","year":"2011","unstructured":"\u2022\u2022The Australo-Anglo-American Spondyloarthritis Consortium (TASC), the Wellcome Trust Case Control Consortium 2 (WTCCC2), Evans DM, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011;43:761\u20137. In this study, ERAP1 was associated with AS in only HLA-B27-positive patients and was in line with similar findings in psoriasis where a genetic interaction between ERAP1 and HLA-C was shown.","journal-title":"Nat Genet"},{"key":"268_CR25","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ng.694","volume":"42","author":"Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2","year":"2010","unstructured":"\u2022\u2022 Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet. 2010;42:985\u201390. The first study to establish a genetic link between ERAP1 and MHC-I. ERAP1 was associated with psoriasis only in HLA-C-positive individuals.","journal-title":"Nat Genet"},{"key":"268_CR26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/annrheumdis-2011-200347","volume":"71","author":"N Haroon","year":"2012","unstructured":"\u2022\u2022 Haroon N, Tsui FW, Uchanska-Ziegler B, et al. Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis. Ann Rheum Dis. 2012;71:589\u201395. This is the first study to establish a functional interaction between ERAP1 and HLA-B27 in AS patients. This study also showed a differential interaction between ERAP1 and HLA-B27 subtypes associated and not associated with AS.","journal-title":"Ann Rheum Dis"},{"key":"268_CR27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1248\/bpb.35.601","volume":"35","author":"A Hattori","year":"2012","unstructured":"Hattori A, Goto Y, Tsujimoto M. Exon 10 coding sequence is important for endoplasmic reticulum retention of endoplasmic reticulum aminopeptidase 1. Biol Pharm Bull. 2012;35:601\u20135.","journal-title":"Biol Pharm Bull"},{"key":"268_CR28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/eji.200635997","volume":"37","author":"S Kollnberger","year":"2007","unstructured":"Kollnberger S, Chan A, Sun MY, et al. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol. 2007;37:1313\u201322.","journal-title":"Eur J Immunol"},{"key":"268_CR29","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.1003337","volume":"186","author":"I Evnouchidou","year":"2011","unstructured":"\u2022\u2022 Evnouchidou I, Kamal RP, Seregin SS, et al. Coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J Immunol. 2011;186:1909\u201313. This study showed that ERAP1 enzymatic action follows substrate inhibition kinetics and that activity of ERAP1 can be influenced by the type and amount of substrate in the reaction.","journal-title":"J Immunol"},{"key":"268_CR30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrrheum.2010.85","volume":"6","author":"N Haroon","year":"2010","unstructured":"Haroon N, Inman RD. Endoplasmic reticulum aminopeptidases: biology and pathogenic potential. Nat Rev Rheumatol. 2010;6:461\u20137.","journal-title":"Nat Rev Rheumatol"},{"key":"268_CR31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.coi.2011.07.006","volume":"23","author":"SL Gaffen","year":"2011","unstructured":"Gaffen SL. Recent advances in the IL-17 cytokine family. Curr Opin Immunol. 2011;23:613\u20139.","journal-title":"Curr Opin Immunol"},{"key":"268_CR32","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","volume":"8","author":"NJ Wilson","year":"2007","unstructured":"Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950\u20137.","journal-title":"Nat Immunol"},{"key":"268_CR33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2012.10901.x","volume":"166","author":"AB Kimball","year":"2012","unstructured":"Kimball AB, Gordon KB, Fakharzadeh S, et al. Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3\u00a0years. Br J Dermatol. 2012;166:861\u201372.","journal-title":"Br J Dermatol"},{"key":"268_CR34","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"\u2022 Leonardi C, Matheson R, Zachariae C, et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med. 2012;366:1190\u20139. One of two studies showing the efficacy of IL-17 blockage in psoriasis.","journal-title":"N Engl J Med"},{"key":"268_CR35","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa1109017","volume":"366","author":"KA Papp","year":"2012","unstructured":"\u2022 Papp KA, Leonardi C, Menter A, et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012;366:1181\u20139. One of two studies showing the efficacy of IL-17 blockage in psoriasis.","journal-title":"N Engl J Med"},{"key":"268_CR36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1155\/2010\/480458","volume":"24","author":"L Cotterill","year":"2010","unstructured":"Cotterill L, Payne D, Levinson S, et al. Replication and meta-analysis of 13,000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease. Can J Gastroenterol. 2010;24:297\u2013302.","journal-title":"Can J Gastroenterol"},{"key":"268_CR37","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/ibd.21912","volume":"18","author":"ER Nimmo","year":"2012","unstructured":"Nimmo ER, Prendergast JG, Aldhous MC, et al. Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway. Inflamm Bowel Dis. 2012;18:889\u201399.","journal-title":"Inflamm Bowel Dis"},{"key":"268_CR38","doi-asserted-by":"crossref","first-page":"e25038","DOI":"10.1371\/journal.pone.0025038","volume":"6","author":"S Pidasheva","year":"2011","unstructured":"\u2022\u2022 Pidasheva S, Trifari S, Phillips A, et al. Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS One. 2011;6:e25038. Functional relevance of the IL23R association in with Crohn\u2019s disease was shown in this study. The R381Q variant had decreased receptor function and was protective in Crohn\u2019s disease.","journal-title":"PLoS One"},{"key":"268_CR39","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4049\/jimmunol.1101494","volume":"188","author":"A Zwiers","year":"2012","unstructured":"Zwiers A, Kraal L, van de Pouw Kraan TC, et al. Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production. J Immunol. 2012;188:1573\u20137.","journal-title":"J Immunol"},{"key":"268_CR40","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00296-010-1769-7","volume":"32","author":"Z Duan","year":"2012","unstructured":"Duan Z, Pan F, Zeng Z, et al. Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Rheumatol Int. 2012;32:1209\u201314.","journal-title":"Rheumatol Int"},{"key":"268_CR41","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","volume":"60","author":"ML DeLay","year":"2009","unstructured":"DeLay ML, Turner MJ, Klenk EI, et al. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 2009;60:2633\u201343.","journal-title":"Arthritis Rheum"},{"key":"268_CR42","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/art.30593","volume":"63","author":"L Zeng","year":"2011","unstructured":"Zeng L, Lindstrom MJ, Smith JA. Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response. Arthritis Rheum. 2011;63:3807\u201317.","journal-title":"Arthritis Rheum"},{"key":"268_CR43","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/art.24568","volume":"60","author":"H Shen","year":"2009","unstructured":"Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60:1647\u201356.","journal-title":"Arthritis Rheum"},{"key":"268_CR44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2008.102277","volume":"69","author":"N Haroon","year":"2010","unstructured":"Haroon N, Tsui FW, O'Shea FD, et al. From gene expression to serum proteins: biomarker discovery in ankylosing spondylitis. Ann Rheum Dis. 2010;69:297\u2013300.","journal-title":"Ann Rheum Dis"},{"key":"268_CR45","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","volume":"13","author":"H Appel","year":"2011","unstructured":"Appel H, Maier R, Wu P, et al. Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther. 2011;13:R95.","journal-title":"Arthritis Res Ther"},{"key":"268_CR46","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/cmi.2010.42","volume":"7","author":"IV Zvyagin","year":"2010","unstructured":"Zvyagin IV, Mamedov IZ, Britanova OV, et al. Contribution of functional KIR3DL1 to ankylosing spondylitis. Cell Mol Immunol. 2010;7:471\u20136.","journal-title":"Cell Mol Immunol"},{"key":"268_CR47","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/ar1988","volume":"8","author":"C Lopez-Larrea","year":"2006","unstructured":"Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, et al. Contribution of KIR3DL1\/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Arthritis Res Ther. 2006;8:R101.","journal-title":"Arthritis Res Ther"},{"key":"268_CR48","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1002\/art.21395","volume":"52","author":"AT Chan","year":"2005","unstructured":"Chan AT, Kollnberger SD, Wedderburn LR, et al. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum. 2005;52:3586\u201395.","journal-title":"Arthritis Rheum"},{"key":"268_CR49","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","volume":"186","author":"P Bowness","year":"2011","unstructured":"\u2022\u2022 Bowness P, Ridley A, Shaw J, et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol. 2011;186:2672\u201380. This study showed that KIR3DL2 receptors are important in increasing the survival and IL-17 production by NK-T cells.","journal-title":"J Immunol"},{"key":"268_CR50","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.33507","volume":"64","author":"TJ Kenna","year":"2012","unstructured":"Kenna TJ, Davidson SI, Duan R, et al. Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive gamma\/delta T cells in patients with active ankylosing spondylitis. Arthritis Rheum. 2012;64:1420\u20139.","journal-title":"Arthritis Rheum"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-012-0268-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-012-0268-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-012-0268-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:49:58Z","timestamp":1559436598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-012-0268-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,11]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["268"],"URL":"https:\/\/doi.org\/10.1007\/s11926-012-0268-0","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,11]]}}}